Back

Dapagliflozin  Tablets

5mg, 10mg

Cardiovascular

details

Dapagliflozin is indicated for the treatment of:

  • Type 2 diabetes mellitus:
    • Treatment of insufficiently controlled type 2 diabetes mellitus in patients aged 18 and above as an adjunct to diet and exercise
    • Monotherapy when metformin is considered inappropriate due to intolerance.
  • Heart Failure: treatment of symptomatic chronic heart failure in adults
  • Chronic kidney disease in adults.
  • ATC4: A10BX
  • Strengths: 5mg & 10mg
  • Dosage Form: Tablets
  • Dossier in CTD format is available for submission

Out-licensing: offered for all international market

* Product availability is subject to patent restrictions in countries where applicable patents are in effect

related products